Author Guidelines

General Principles

All manuscripts must be submitted via the online portal at https://actapulmonologica.or.id

  • Originality: Manuscripts must be original, have not been published previously, and are not currently under consideration by another journal. A similarity check (e.g., Turnitin) will be performed upon submission.
  • Language: All manuscripts must be written in clear, concise US English. Authors whose first language is not English are encouraged to have their manuscripts proofread by a professional editor.
  • Compliance: Manuscripts must adhere to the ICMJE "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals."
  • Editorial Authority: The Board reserves the right to edit for style, clarity, and format. Manuscripts with significant linguistic or formatting errors may be rejected or returned for revision.
  • Peer Review: All submissions undergo rigorous peer and editorial review.

 

Accepted Article Types

  • Original Articles (Basic, Clinical, or Community Research) (ORI)
  • Case Reports (CAS)
  • Review Articles (REV)

 

Required Documents for Submission

  • Completed ICMJE Conflict of Interest forms for all authors.
  • Formal Cover Letter (including statements on prior presentations or redundant publication).
  • Copy of Ethical Approval (if applicable).
  • A Final Checklist signed by all authors.

 

Study Ethics & Informed Consent

  • Institutional Review: Any study involving human subjects or animal experimentation must include a statement of approval from an independent ethics committee.
  • Patient Privacy: In accordance with global data protection standards, all identifiers (names, birth dates, medical record numbers) must be removed.
  • Visual Data: Patient faces must be blurred; eyes should be concealed with black bars. De-identification is required for all diagnostic imaging (CT, X-ray, Ultrasound).
  • Consent: Written informed consent for publication is mandatory. If a waiver was granted by an ethics committee, the official waiver letter must be uploaded.
  • Clinical Trials: Must be registered in a public database (e.g., gov or WHO ICTRP) prior to the start of the study. The registration number must be listed at the end of the abstract.
  • Systematic Reviews: Registration with PROSPERO is strongly encouraged before data extraction begins.

 

Formatting

  • File format: Microsoft Word (.doc or .docx)
  • Font: Times New Roman, 12pt.
  • Spacing: Double-spaced throughout.
  • Margins: A4 paper size with 2.5 cm (1 inch) on all sides.
  • Page numbers: Placed at the bottom right of each page.
  • File Naming:  (First Author’s Surname)-(ORI/CR/REV).docx

 

Manuscript Structure 

  • Order: Title Page (submitted as a separate file for double-blind review), 2. Abstract and Keywords, 3. Main Text, 4. Conflicts of Interest & Funding Disclosures 5. Acknowledgments, 6. References,7. Tables, Figures, and Legends
  • Title Page
    • Title: Concise and informative (max 20 words); capitalize each word.
    • Running Title: Max 140 characters including spaces.
    • Author Details: Includes the full title, author names, affiliations, and the corresponding author’s email.
  • Abstract
    • ORI: Structured (Background, Method, Result, Conclusion) – max 250 words.
    • CAS/REV: Unstructured – max 150 words.
  • Keywords: 3 to 10 terms, separated by commas.
  • Main Text
    • Original Article: Introduction, Methods, Results, and Discussion(IMRAD)
    • Case Report: Intro, Background, Case Description, Discussion, Conclusion
    • Review: Intro, Literature Review, Conclusion

 

Tables and Figures

  • Tables and Figures must be numbered consecutively (e.g., Table 1, Figure 1) and cited in the text.
    • Tables should be editable (not images) with a descriptive title above.
    • Figures must be high resolution (minimum 300 dpi) in JPEG or TIFF format with captions below.
  • It is recommended to limit the combined total of tables and figures to six.
  • If using previously published material, authors must provide written permission from the copyright holder.
  • Large datasets, videos, or extensive appendices may be submitted as supplementary materials.

 

Disclosure and Funding

  • Conflict of Interest: Authors must declare any financial or personal relationships that could inappropriately influence their work. If none exist, state: "The authors declare no conflict of interest."
  • Funding: Specify any sources of financial support for the research.
  • Acknowledgement: Recognize individuals who contributed to the work but do not meet the criteria for authorship.

 

References

  • Style: Follow the Vancouver
  • Citations: Use Arabic numerals in superscript following the order of appearance.
  • Management: Use of software like Mendeley, Zotero, or EndNote is highly recommended.

Journal Articles

  1. Standard Article (Up to 6 authors):

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.

  1. More than 6 authors:

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60.

  1. Organization as Author:

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. Madison (WI): GOLD; 2023.

  1. Journal Article with DOI (Preferred for online-first):

Bousquet J, Anto JM, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 report. J Allergy Clin Immunol. 2020;145(1):70-80. doi: 10.1016/j.jaci.2019.06.049.

 

Books and Monographs

  1. Personal Author(s):

Grippi MA, Antin-Ozerkis DE, Elias JA, Kotloff RM. Fishman's Pulmonary Diseases and Disorders. 6th ed. New York: McGraw Hill; 2023.

  1. Chapter in an Edited Book:

Lumb AB, Thomas CR. Carbon dioxide. In: Lumb AB, Thomas CR, editors. Nunn's Applied Respiratory Physiology. 9th ed. St Louis (MO): Elsevier; 2020. p. 135-50.

 

Scientific Reports and Grey Literature

  1. Government/Official Report:

World Health Organization. Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.

  1. Dissertation/Thesis:

Smith J. Precision medicine in interstitial lung disease [dissertation]. London: Imperial College London; 2022.

 

Electronic and Digital Media

  1. Webpage/Homepage:

Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease (COPD) [Internet]. Atlanta: CDC; 2024 [updated 2024 Jan 15; cited 2024 Feb 10]. Available from: https://www.cdc.gov/copd/index.html

  1. Preprint (Work not yet peer-reviewed):

Doe J, Roe R. Longitudinal lung function in post-viral syndrome. medRxiv. [Preprint]. 2023 [cited 2024 Jan 5]: [12 p.]. Available from: https://doi.org/10.1101/2023.01.01.23284000

 

 

Copyright

Licensing: Authors retain copyright but grant Acta Pulmonologica the right to publish under a CC BY-NC 4.0 license.